$CHMX
NEXT-ChemX Corporation. Stock $chmx

$chmx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224012269 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$482.1K	$554.9K	$1.977M
YoY Change	10.42%	17.32%	18.13%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.330K	$1.340K	$5.340K
YoY Change	0.0%	0.75%	3.49%
% of Gross Profit
Operating Expenses	$482.1K	$554.9K	$1.977M
YoY Change	10.42%	17.32%	18.13%
Operating Profit	-$482.1K		-$1.977M
YoY Change	10.42%		18.13%
Interest Expense	-$36.83K	-$27.74K	$87.68K
YoY Change	-272.75%	3.05%	24.35%
% of Operating Profit
Other Income/Expense, Net	-$36.83K	$0.00	-$384.6K
YoY Change	72.73%		445.46%
Pretax Income	-$519.0K	-$582.7K	-$2.361M
YoY Change	13.32%	16.55%	35.41%
Income Tax
% Of Pretax Income
Net Earnings	-$519.0K	-$582.7K	-$2.361M
YoY Change	13.32%	16.55%	35.41%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02		-$0.08
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.08
COMMON SHARES
Basic Shares Outstanding	28.55M shares	28.55M shares	28.47M shares
Diluted Shares Outstanding	28.55M shares		28.47M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$139.7K	$67.40K	$67.40K
YoY Change	-1.74%	137.66%	137.66%
Cash & Equivalents	$94.77K	$2.458K	$2.460K
Short-Term Investments	$44.96K	$64.94K	$64.94K
Other Short-Term Assets	$44.96K	$64.94K	$72.93K
YoY Change	237.26%	192.94%	228.96%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$216.8K	$140.3K	$140.3K
YoY Change	39.41%	177.74%	177.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.29K	$12.62K	$12.62K
YoY Change	-32.1%	-29.72%	-29.73%
Goodwill
YoY Change
Intangibles	$3.150M	$3.150M
YoY Change	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.161M	$3.163M	$3.163M
YoY Change	-0.17%	-0.17%	-0.17%
TOTAL ASSETS
Total Short-Term Assets	$216.8K	$140.3K	$140.3K
Total Long-Term Assets	$3.161M	$3.163M	$3.163M
Total Assets	$3.378M	$3.303M	$3.303M
YoY Change	1.68%	2.62%	2.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$803.0K	$2.443M	$2.443M
YoY Change	51.63%	57.75%	57.75%
Accrued Expenses	$1.829M
YoY Change	59.11%
Deferred Revenue
YoY Change
Short-Term Debt	$1.017M	$977.2K	$977.2K
YoY Change	18.7%	5.53%	5.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.162M	$3.932M	$3.932M
YoY Change	63.3%	58.14%	58.14%
LONG-TERM LIABILITIES
Long-Term Debt	$365.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$365.0K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.162M	$3.932M	$3.932M
Total Long-Term Liabilities	$365.0K	$0.00	$0.00
Total Liabilities	$4.527M	$3.932M	$3.932M
YoY Change	77.63%	58.14%	58.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.573M	-$6.054M
YoY Change	58.36%	63.94%
Common Stock	$28.55K	$28.55K
YoY Change	0.35%	0.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.148M	-$629.4K	-$629.4K
YoY Change
Total Liabilities & Shareholders Equity	$3.378M	$3.303M	$3.303M
YoY Change	1.68%	2.62%	2.62%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$519.0K	-$582.7K	-$2.361M
YoY Change	13.32%	16.55%	35.41%
Depreciation, Depletion And Amortization	$1.330K	$1.340K	$5.340K
YoY Change	0.0%	0.75%	3.49%
Cash From Operating Activities	-$292.7K	-$178.4K	-$544.9K
YoY Change	-5.63%	-60.01%	-41.73%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$500.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$385.0K	120.0K	$519.0K
YoY Change	-9.2%	-74.71%	-45.63%
NET CHANGE
Cash From Operating Activities	-$292.7K	-178.4K	-$544.9K
Cash From Investing Activities		0.000
Cash From Financing Activities	$385.0K	120.0K	$519.0K
Net Change In Cash	$92.31K	-58.43K	-$25.90K
YoY Change	-18.92%	-306.76%	-244.47%
FREE CASH FLOW
Cash From Operating Activities	-$292.7K	-$178.4K	-$544.9K
Capital Expenditures		$0.00
Free Cash Flow	-$292.7K	-$178.4K	-$544.9K
YoY Change	-5.63%	-60.01%	-41.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001657045
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2022	CHMX	Consultant Commission Paid In Third Party Stock ConsultantCommissionPaidInThirdPartyStock		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	CHMX	Common Stock Issued On Conversion Of3rd Party Loan CommonStockIssuedOnConversionOf3rdPartyLoan		usd
CY2023	CHMX	Common Stock Issued On Conversion Of Related Party Loan CommonStockIssuedOnConversionOfRelatedPartyLoan		usd
CY2023Q4	CHMX	Deferred Tax Assets Amortization Of Fair Value Of Stock For Services DeferredTaxAssetsAmortizationOfFairValueOfStockForServices		usd
CY2022Q4	CHMX	Deferred Tax Assets Amortization Of Fair Value Of Stock For Services DeferredTaxAssetsAmortizationOfFairValueOfStockForServices		usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2023Q4	CHMX	Deferred Tax Asset Net Non Current DeferredTaxAssetNetNonCurrent		usd
CY2022Q4	CHMX	Deferred Tax Asset Net Non Current DeferredTaxAssetNetNonCurrent		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56379
CY2023	dei	Entity Registrant Name EntityRegistrantName	NEXT-CHEMX CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	32-0446353
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1980 Festival Plaza Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Summerlin South 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89135
CY2023	dei	City Area Code CityAreaCode	725
CY2023	dei	Local Phone Number LocalPhoneNumber	867-0789
CY2023	dei	Security12g Title Security12gTitle	Common Stock, par value $0.001
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	41679153.00	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28546834	shares
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash Cash	2458	usd
CY2022Q4	us-gaap	Cash Cash	28355	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	72925	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22169	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	64944	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	140327	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50524	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12621	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17957	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3150114	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3150114	usd
CY2023Q4	us-gaap	Assets Assets	3303062	usd
CY2022Q4	us-gaap	Assets Assets	3218595	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2443207	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1548740	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	426007	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	945000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27802153	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1712486	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	686505	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	500000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3932425	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2486727	usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1976601	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1673284	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1976601	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1673284	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1976601	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1673284	usd
CY2023	us-gaap	Interest Expense InterestExpense	87682	usd
CY2022	us-gaap	Interest Expense InterestExpense	70515	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-296948	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-384630	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-70515	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2361231	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1743799	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2361231	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1743799	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28466560	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28466560	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27802153	shares
CY2022	CHMX	Stock Issued During Period Value Conversion Of Related Party StockIssuedDuringPeriodValueConversionOfRelatedParty	76676	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1743799	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	731868	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	731868	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	500000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	500000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2361231	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-629363	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-629363	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2361231	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1743799	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5336	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5160	usd
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome	203050	usd
CY2023	us-gaap	Debt Securities Trading Unrealized Loss DebtSecuritiesTradingUnrealizedLoss	36581	usd
CY2023	CHMX	Consultant Commission Paid In Third Party Stock ConsultantCommissionPaidInThirdPartyStock	101525	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	500000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1394467	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	824125	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	50756	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	20570	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	32238	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-544890	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-935084	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1577	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1577	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	60000	usd
CY2023	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	465000	usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	500000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	556007	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	11980	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	37500	usd
CY2023	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	20000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	426007	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	130000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5900	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	518993	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	954587	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25897	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17926	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28355	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10429	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2458	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28355	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	37212	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	14022	usd
CY2022	CHMX	Common Stock Issued On Conversion Of3rd Party Loan CommonStockIssuedOnConversionOf3rdPartyLoan	686505	usd
CY2022	CHMX	Common Stock Issued On Conversion Of Related Party Loan CommonStockIssuedOnConversionOfRelatedPartyLoan	76677	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28546834	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28546834	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6053963	usd
CY2023Q4	CHMX	Working Capital Deficit WorkingCapitalDeficit	3792098	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3692732	usd
CY2022Q4	CHMX	Working Capital Deficit WorkingCapitalDeficit	2436203	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zlNaBhuGVP31" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_ztUOLe9VOFEk">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Cash	2458	usd
CY2022Q4	us-gaap	Cash Cash	28355	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	72925	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22169	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	350014	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3150114	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2443207	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1548740	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	250000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2361231	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1743799	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1271332	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	775474	usd
CY2023Q4	CHMX	Deferred Tax Assets Non Current DeferredTaxAssetsNonCurrent	1271332	usd
CY2022Q4	CHMX	Deferred Tax Assets Non Current DeferredTaxAssetsNonCurrent	775474	usd
CY2023Q4	CHMX	Deferred Tax Asset Valuation Allowance Noncurrent DeferredTaxAssetValuationAllowanceNoncurrent	-1271332	usd
CY2022Q4	CHMX	Deferred Tax Asset Valuation Allowance Noncurrent DeferredTaxAssetValuationAllowanceNoncurrent	-775474	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28346834	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28546834	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	200000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.25

Files In Submission

Name	View Source	Status
0001493152-24-012269-index-headers.html	Edgar Link	pending
0001493152-24-012269-index.html	Edgar Link	pending
0001493152-24-012269.txt	Edgar Link	pending
0001493152-24-012269-xbrl.zip	Edgar Link	pending
chmx-20231231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
chmx-20231231_cal.xml	Edgar Link	unprocessable
chmx-20231231_def.xml	Edgar Link	unprocessable
chmx-20231231_lab.xml	Edgar Link	unprocessable
chmx-20231231_pre.xml	Edgar Link	unprocessable
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHMX
NEXT-ChemX Corporation. Stock $chmx

2024 Q1 Form 10-K Financial Statement

#000149315224012269 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHMX NEXT-ChemX Corporation. Stock $chmx

2024 Q1 Form 10-K Financial Statement

#000149315224012269 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHMX
NEXT-ChemX Corporation. Stock $chmx